Methyl (S)-2-amino-2-(2-chlorophenyl)acetate, 97%, 5g

1-(2-piridilazo)-2-naftol, mínimo 98 %, pa, ACS, 5 g, envase de vidrio

3-Chloro-4-(trifluoromethoxy)benzenesulfonyl chloride, 95.0%, 5g

4-(Bromoacetyl)pyridine hydrobromide, 25g

2-(2-Bromobenzyl)-3-methylbutanoic acid, 98%, 500mg

5-(Trifluoromethyl)quinolin-8-amine, 95.0%, 1g

[(2S)-2-METHYLOXETAN-2-YL]METHANOL, 95%, 100mg

4,4'-Di-tert-butylbenzophenone, 97.0%, 5g

N-(tert-Butoxycarbonyl)-D-serine>98.0%(HPLC)(T)5g

8-Chloro-1,7-naphthyridine-3-carbaldehyde, 98%, 1g

4-Bromo-1,2-difluoro-3-(methoxymethoxy)benzene, 98%, 1g

9-Bromo-10-[4-(2-naphthyl)phenyl]anthracene>98.0%(HPLC)1g

(1S,2S)-2-(4-CHLOROPHENYL)CYCLOPROPANE-1-CARBOXYLIC ACID, 95.0%, 1g